Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) released earnings for full year that Dropped, from last year
The company's bottom line came in at RMB187.751 million, or RMB0.18 per share. This compares with RMB243.525 million, or RMB0.24 per share, last year.
The company's revenue for the period fell 8.3% to RMB3.650 billion from RMB3.982 billion last year.
Lushang Freda Pharmaceutical Co.,Ltd. earnings at a glance (GAAP) :
-Earnings: RMB187.751 Mln. vs. RMB243.525 Mln. last year.-EPS: RMB0.18 vs. RMB0.24 last year.-Revenue: RMB3.650 Bln vs. RMB3.982 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.